CLARIVEST ASSET MANAGEMENT LLC Denali Therapeutics Inc. Transaction History

CLARIVEST ASSET MANAGEMENT LLC portfolio value:

$1.51M
portfolio value

CLARIVEST ASSET MANAGEMENT LLC quarter portfolio value change:

+4.28%
quarter

Denali Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -9.62% -5.25K shares -93K $30.69 49.38K
Q2 2022 share Decrease -16.76% -11K shares -504K $29.43 54.63K
Q1 2022 share 0.00% 0 shares -816K $32.17 65.63K
Q4 2021 share Decrease -8.15% -5.82K shares -679K $45.05 65.63K
Q3 2021 share Decrease -5.02% -3.77K shares -2.29M $50.45 71.46K
Q2 2021 share Increase +337.32% 58.03K shares 4.92M $78.44 75.24K
Q1 2021 share Increase +2.83% 473 shares -420K $57.1 17.20K
Q4 2020 share Decrease -57.63% -22.76K shares -12K $83.76 16.73K
Q3 2020 share Increase +26.03% 8.15K shares 657K $35.83 39.49K
Q2 2020 share Increase 0.00% 31.33K shares 757K $24.18 31.33K